MAPK1 and juvenile myelomonocytic leukemia: Patients with pathogenic variants in the Ras-ERK pathway (Ras-opathies) can present with a broad array of clinical features, including features associated with inborn errors of immunity (IEI), predisposition to malignancy (JMML) and autoimmunity [2, 3].